Kutok joins Epizyme as CSO; plus ADC Therapeutics, Emulate, E-Scape, MiMedx and RubrYc

Epizyme Inc. (NASDAQ:EPZM) hired Jeffery Kutok as CSO. He was EVP and CSO of Infinity Pharmaceuticals Inc. (NASDAQ:INFI). Kutok joins the epigenetics company in the wake of its first FDA approval, for Tazverik tazemetostat to treat epitheliod sarcoma (see "Epizyme Scores First FDA Approval").

Antibody-drug conjugate company ADC Therapeutics S.A. appointed Ron Squarer as chairman. He succeeds Peter Corr, who will remain on the board. Squarer was CEO of Array BioPharma Inc...